Cologne, Germany

Rolf Madaus

This inventor holds 1 USPTO granted patent. Top assignee: Dr. Madaus & Co.. Active years: 1976.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rolf Madaus. Retrieved from https://idiyas.com/inventor/rolf-madaus

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rolf Madaus: Innovator in Anti-Bacterial and Anti-Mycotic Therapies

Introduction

Rolf Madaus is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with strong anti-bacterial and anti-mycotic properties. His work has implications for improving therapeutic options in mustard oil therapy.

Latest Patents

Rolf Madaus holds a patent for the compound .alpha.-Amino-.beta.-(N-benzylthiocarbamoylthio) propionic acid. This innovative compound provides strong anti-bacterial and anti-mycotic action, coupled with excellent stability and tolerability when administered orally. This advancement is particularly relevant in the context of mustard oil therapy.

Career Highlights

Madaus is associated with Dr. Madaus & Co., where he has been instrumental in research and development. His work has led to advancements in pharmaceutical formulations that enhance patient care and treatment outcomes.

Collaborations

Rolf Madaus has collaborated with Gerhard Brusewitz, contributing to the development of innovative therapeutic solutions. Their partnership has focused on enhancing the efficacy of anti-bacterial and anti-mycotic treatments.

Conclusion

Rolf Madaus is a prominent figure in the pharmaceutical industry, recognized for his innovative contributions to anti-bacterial and anti-mycotic therapies. His work continues to influence the field and improve treatment options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…